Reaction

Cutaneous Vasculitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,524 reports · 143 co-occurring drugs

As of the last recalculation, Cutaneous Vasculitis appears in 3,524 FAERS reports alongside 143 co-occurring drug terms. The strongest observed disproportionality signal is ANAKINRA (PRR 43.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Anakinra	117	43.1	43.4
Daptomycin	29	18.7	18.8
Itraconazole	32	16.3	16.4
Cefazolin Sodium	32	15.8	15.9
Cladribine	23	14.2	14.3
Piperacillin Sodium,Tazobactam Sodium	61	13.8	13.8
Rifampin	33	13.5	13.5
Colchicine	59	13.4	13.5
Piperacillin And Tazobactam	28	13.0	13.1
Methimazole	17	12.8	12.9
Cefazolin	19	12.4	12.4
Vancomycin Hydrochloride	111	10.2	10.3
Hydroxychloroquine	119	9.7	9.7
Nebivolol	26	9.7	9.7
Apixaban	103	9.3	9.3
Ciprofolxacin	110	9.3	9.3
Ciprofloxacin Tablets	110	9.3	9.3
Vancomycin	88	9.2	9.2
Tocilizumab	168	9.1	9.1
Ketoprofen	20	9.0	9.1
Cefuroxime	17	8.8	8.8
Piperacillin Sodium And Tazobactam Sodium	29	8.8	8.8
Terbinafine Hydrochloride	13	8.7	8.7
Cefepime	20	8.3	8.3
Cefepime Hydrochloride	21	7.7	7.7
Desloratadine	14	7.7	7.7
Valacyclovir	53	7.6	7.6
Atovaquone	10	7.4	7.4
Ciprofloxacin	111	7.3	7.4
Clindamycin Phosphate	41	7.3	7.3
Ciprofloxacin Hydrochloride	117	7.3	7.3
Daspone	12	7.3	7.3
Dapsone Gel, 5%	12	7.3	7.3
Gentamicin	16	7.3	7.3
Adalimumab-Fkjp	55	7.1	7.1
Instalax Polyethylene Glycol 3350	14	6.7	6.7
Dapsone	12	6.7	6.7
Adalimumab-Aaty	52	6.6	6.6
Polyethylene Glycol 400	14	6.5	6.5
Clindamycin	31	6.5	6.5
Gentamicin Sulfate	17	6.4	6.4
Adalimumab-Adaz	56	6.4	6.4
Tofacitinib Citrate	14	6.3	6.3
Pyrazinamide	10	6.3	6.3
Azathioprine	91	6.2	6.2
Amphotericin B	13	6.1	6.2
Nitrofurantoin (Monohydrate/Macrocrystals)	17	6.0	6.0
Leflunomide	104	6.0	6.0
Dapagliflozin	31	5.9	5.9
Tamsulosin Hydrochloride	20	5.8	5.8
Nitrofurantoin	16	5.8	5.8
Hydroxychloroquine Sulfate	86	5.7	5.7
Indapamide	17	5.6	5.6
Linezolid	28	5.6	5.6
Anastrozole Tablets	20	5.5	5.5
Cetiirizine	39	5.5	5.5
Canakinumab	10	5.5	5.5
Esomeprazole	56	5.4	5.4
Meropenem	29	5.4	5.4
Brimonidine Tartrate	16	5.3	5.3
Abatacept	121	5.3	5.3
Enalapril Maleate	22	5.3	5.3
Rifampicin	9	5.3	5.3
Valsartan Oral	47	5.2	5.2
Levofloxacin	52	5.2	5.2
Levofloxacin In 5% Dextrose	52	5.2	5.2
Valacyclovir Hydrochloride	60	5.1	5.1
Enoxaparin Sodium	49	5.1	5.1
Naproxen	66	5.0	5.0
Azithromycin	34	5.0	5.0
Amoxicillin And Clavulanate Potassium	23	5.0	5.0
Acetylcysteine	8	5.0	5.0
Clarithromycin	29	5.0	5.0
Metformin Hydrochloride Tablets	48	5.0	5.0
Metformin Hydrochloride Extended-Release Tablets	48	5.0	5.0
Metformin Hydrochloride Tablet	48	5.0	5.0
Azithromycin Monohydrate	34	4.9	4.9
Metformin Hydrochloride	48	4.8	4.8
Enalapril	45	4.8	4.8
Prednisolone Oral Solution	141	4.8	4.8
Prednisolone	140	4.7	4.7
Prednisolone Oral	140	4.7	4.7
Oxazepam	17	4.7	4.7
Bicalutamide	12	4.7	4.7
Ceftriaxone Sodium	30	4.7	4.7
Bisoprolol Fumarate	104	4.6	4.6
Clobetasol Propionate Ointment Usp, 0.05%	8	4.6	4.6
Clobetasol Propionate	8	4.6	4.6
Nebivolol Hydrochloride	26	4.6	4.6
Prednisolone Acetate	8	4.6	4.6
Ceftriaxone	25	4.5	4.5
Dorzolamide Hydrochloride And Timolol Maleate	6	4.5	4.5
Isoniazid	12	4.4	4.4
Durvalumab	15	4.4	4.4
Metolazone	8	4.2	4.2
Allopurinol	108	4.2	4.2
Irbesartan	31	4.1	4.1
Febuxostat Tablets 40 Mg	7	4.1	4.1
Febuxostat Tablets 80 Mg	7	4.1	4.1
Zoledronic Acid	27	4.0	4.0
Cetirizine	51	3.9	3.9
Insulin Glargine-Yfgn	14	3.8	3.8
Amlodipine	166	3.8	3.8
Infliximab	135	3.8	3.8
Letrozole Tablets	29	3.6	3.6
Ipilimumab	26	3.6	3.6
Sitagliptin And Metformin Hydrochloride	13	3.6	3.6
Sirolimus	8	3.5	3.5
Empagliflozin	39	3.4	3.4
Olaparib	12	3.4	3.4
Erlotinib Hydrochloride	7	3.3	3.3
Tofacitinib	99	3.2	3.2
Erlotinib	5	3.1	3.1
Ixekizumab	19	3.0	3.0
Levocetirizine Dihydrochloride	12	3.0	3.0
Lifitegrast	8	2.9	2.9
Blinatumomab	5	2.8	2.8
Ado-Trastuzumab Emtansine	4	2.8	2.8
Tenofovir Disoproxil Fumarate Tablets	4	2.7	2.7
Fesoterodine Fumarate	5	2.7	2.7
Golimumab	35	2.4	2.4
Ustekinumab	40	2.3	2.3
Azacitidine For	7	2.3	2.3
Nivolumab	37	2.3	2.3
Gemcitabine	15	2.3	2.3
Pemetrexed	8	2.2	2.2
Ravulizumab	5	2.2	2.2
Atezolizumab	14	2.1	2.1
Emtricitabine And Tenofovir Disoproxil Fumarate	16	2.1	2.1
Daratumumab	14	2.1	2.1
Benralizumab	7	2.1	2.1
Azacitidine	10	2.0	2.0
Etanercept	195	2.0	2.0
Bendamustine Hydrochloride	4	2.0	2.0
Vemurafenib	4	2.0	2.0
Gefitinib	3	2.0	2.0
Cabozantinib	14	1.7	1.7
Certolizumab Pegol	33	1.7	1.7
Tafamidis	3	1.5	1.5
Osimertinib	8	1.5	1.5
Ixazomib	7	1.4	1.4
Guselkumab	8	1.3	1.3
Bimekizumab	4	1.1	1.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.